Bank of New York Mellon’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.8M | Sell |
413,684
-59,190
| -13% | -$2.54M | ﹤0.01% | 1628 |
|
|
2026
Q1 | $17.4M | Sell |
472,874
-130,726
| -22% | -$6.19M | ﹤0.01% | 1616 |
|
|
2025
Q4 | $30.7M | Sell |
603,600
-68,056
| -10% | -$3.48M | 0.01% | 1289 |
|
|
2025
Q3 | $37.3M | Sell |
671,656
-133,911
| -17% | -$7.84M | 0.01% | 1194 |
|
|
2025
Q2 | $55.6M | Sell |
805,567
-34,235
| -4% | -$2.33M | 0.01% | 930 |
|
|
2025
Q1 | $58.3M | Buy |
839,802
+47,804
| +6% | +$3.95M | 0.01% | 875 |
|
|
2024
Q4 | $68.1M | Sell |
791,998
-21,423
| -3% | -$2.32M | 0.01% | 828 |
|
|
2024
Q3 | $96.9M | Buy |
813,421
+4,854
| +0.6% | +$647K | 0.02% | 664 |
|
|
2024
Q2 | $115M | Buy |
808,567
+13,824
| +2% | +$1.83M | 0.02% | 573 |
|
|
2024
Q1 | $102M | Sell |
794,743
-7,134
| -0.9% | -$849K | 0.02% | 648 |
|
|
2023
Q4 | $83M | Sell |
801,877
-61,721
| -7% | -$6.1M | 0.02% | 744 |
|
|
2023
Q3 | $78.5M | Sell |
863,598
-12,814
| -1% | -$1.13M | 0.02% | 743 |
|
|
2023
Q2 | $70.9M | Buy |
876,412
+24,698
| +3% | +$2.02M | 0.01% | 813 |
|
|
2023
Q1 | $67.8M | Sell |
851,714
-50,442
| -6% | -$3.58M | 0.01% | 825 |
|
|
2022
Q4 | $61M | Sell |
902,156
-67,192
| -7% | -$3.94M | 0.01% | 867 |
|
|
2022
Q3 | $48.3M | Sell |
969,348
-54,642
| -5% | -$2.93M | 0.01% | 977 |
|
|
2022
Q2 | $57.1M | Buy |
1,023,990
+43,458
| +4% | +$2.41M | 0.01% | 900 |
|
|
2022
Q1 | $54.4M | Buy |
980,532
+95,806
| +11% | +$4.92M | 0.01% | 1038 |
|
|
2021
Q4 | $49.5M | Buy |
884,726
+59,410
| +7% | +$3.22M | 0.01% | 1175 |
|
|
2021
Q3 | $39.6M | Buy |
825,316
+94,824
| +13% | +$4.58M | 0.01% | 1289 |
|
|
2021
Q2 | $30.6M | Buy |
730,492
+55,540
| +8% | +$2.15M | 0.01% | 1483 |
|
|
2021
Q1 | $22.8M | Buy |
674,952
+84,300
| +14% | +$3M | ﹤0.01% | 1635 |
|
|
2020
Q4 | $20.6M | Buy |
590,652
+63,990
| +12% | +$2.21M | ﹤0.01% | 1619 |
|
|
2020
Q3 | $18.3M | Buy |
526,662
+5,640
| +1% | +$188K | ﹤0.01% | 1534 |
|
|
2020
Q2 | $17.1M | Sell |
521,022
-1,592,914
| -75% | -$50.8M | ﹤0.01% | 1541 |
|
|
2020
Q1 | $63.6M | Buy |
2,113,936
+11,564
| +0.6% | +$344K | 0.02% | 650 |
|
|
2019
Q4 | $60.8M | Sell |
2,102,372
-30,730
| -1% | -$851K | 0.02% | 860 |
|
|
2019
Q3 | $55.1M | Buy |
2,133,102
+23,036
| +1% | +$583K | 0.02% | 889 |
|
|
2019
Q2 | $53.8M | Sell |
2,110,066
-19,618
| -0.9% | -$485K | 0.01% | 928 |
|
|
2019
Q1 | $55.7M | Sell |
2,129,684
-14,194
| -0.7% | -$349K | 0.02% | 888 |
|
|
2018
Q4 | $49.4M | Sell |
2,143,878
-117,700
| -5% | -$2.62M | 0.02% | 890 |
|
|
2018
Q3 | $53.3M | Sell |
2,261,578
-80,734
| -3% | -$1.97M | 0.01% | 977 |
|
|
2018
Q2 | $54M | Sell |
2,342,312
-150,268
| -6% | -$3.57M | 0.01% | 949 |
|
|
2018
Q1 | $61.4M | Sell |
2,492,580
-121,332
| -5% | -$3.19M | 0.02% | 864 |
|
|
2017
Q4 | $70.1M | Sell |
2,613,912
-60,248
| -2% | -$1.53M | 0.02% | 805 |
|
|
2017
Q3 | $64.4M | Sell |
2,674,160
-128,622
| -5% | -$2.91M | 0.02% | 828 |
|
|
2017
Q2 | $60.1M | Sell |
2,802,782
-229,288
| -8% | -$4.63M | 0.02% | 849 |
|
|
2017
Q1 | $52M | Sell |
3,032,070
-205,146
| -6% | -$3.57M | 0.01% | 938 |
|
|
2016
Q4 | $58M | Sell |
3,237,216
-377,938
| -10% | -$6.85M | 0.02% | 839 |
|
|
2016
Q3 | $75.2M | Sell |
3,615,154
-208,958
| -5% | -$5.18M | 0.02% | 665 |
|
|
2016
Q2 | $103M | Sell |
3,824,112
-233,160
| -6% | -$6.39M | 0.03% | 514 |
|
|
2016
Q1 | $110M | Sell |
4,057,272
-619,820
| -13% | -$16.6M | 0.03% | 498 |
|
|
2015
Q4 | $136M | Sell |
4,677,092
-719,148
| -13% | -$19.9M | 0.04% | 420 |
|
|
2015
Q3 | $146M | Sell |
5,396,240
-1,139,448
| -17% | -$32.3M | 0.04% | 402 |
|
|
2015
Q2 | $179M | Sell |
6,535,688
-800,938
| -11% | -$22.5M | 0.05% | 386 |
|
|
2015
Q1 | $196M | Sell |
7,336,626
-15,800
| -0.2% | -$364K | 0.05% | 385 |
|
|
2014
Q4 | $156M | Sell |
7,352,426
-694,566
| -9% | -$15.5M | 0.04% | 424 |
|
|
2014
Q3 | $192M | Sell |
8,046,992
-33,824
| -0.4% | -$778K | 0.05% | 367 |
|
|
2014
Q2 | $187M | Sell |
8,080,816
-146,234
| -2% | -$3.23M | 0.05% | 381 |
|
|
2014
Q1 | $188M | Sell |
8,227,050
-41,470
| -0.5% | -$884K | 0.05% | 368 |
|
|
2013
Q4 | $153M | Sell |
8,268,520
-196,510
| -2% | -$3.42M | 0.04% | 426 |
|
|
2013
Q3 | $143M | Sell |
8,465,030
-1,000,300
| -11% | -$16.8M | 0.04% | 439 |
|
|
2013
Q2 | $147M | Buy |
+9,465,330
| New | +$158M | 0.05% | 407 |
|
Other funds holding NVO
EHC
SRIM
N
MG
Bank of New York Mellon's NVO Position: Q2 2026 in Review
Bank of New York Mellon reduced its Novo Nordisk (NVO) stake by 13% in Q2 2026, selling an estimated $2.54M and leaving 413,684 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1628.
Bank of New York Mellon first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $196M in Q1 2015. 970 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Bank of New York Mellon held 413,684 shares of Novo Nordisk worth $19.8M as of Q2 2026.
- Bank of New York Mellon sold 59,190 Novo Nordisk shares in Q2 2026, an estimated $2.54M.
- Novo Nordisk made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1628 holding.
- Bank of New York Mellon first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Novo Nordisk position peaked at $196M in Q1 2015.
- 970 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.